BMJ10.1136/bmj.n19332021n1933Covid-19: Delta infections threaten herd immunity vaccine strategyOwen Dyer,
Vaccine10.1016/j.vaccine.2021.04.0422021Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, AustraliaC. Raina MacIntyre, Valentina Costantino, Mallory Trent,
Vaccine10.1016/j.vaccine.2003.07.0162004223-4301-302Herd immunity and herd protectionYash Paul,
Perspectives in Public Health10.1177/175791392096301220201406301-302Tackling sheepishness about a COVID-19 vaccine for the sake of herd immunityFlorence Gildea,,
Antimicrobial Stewardship & Healthcare Epidemiology10.1017/ash.2021.10120211S1s52-s52COVID-19 Vaccine Superstations as a Model to Rapidly Achieve Herd ImmunityJocelyn Keehner, Francesca Torriani, Shira Abeles, Lucy Horton
Immunity10.1016/j.immuni.2020.04.0122020525737-741Herd Immunity: Understanding COVID-19Haley E. Randolph, Luis B. Barreiro,
BMJ10.1136/bmj.m37142020m3714Covid-19: The fatal attraction of herd immunityKamran Abbasi,
Vaccines10.3390/vaccines9050489202195489Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd ImmunityJames E. K. Hildreth, Donald J. Alcendor
European Journal of Operational Research10.1016/j.ejor.2021.03.0302021Strategies for ensuring required service level for COVID-19 herd immunity in Indian vaccine supply chainPriyank Sinha, Sameer Kumar, Charu Chandra,
Frontiers in Immunology10.3389/fimmu.2020.01817202011The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization StrategiesLea Skak Filtenborg Frederiksen, Yibang Zhang, Camilla Foged, Aneesh Thakur